Boston University Medical Center General Clinical Research Unit is a clinical research site located in Boston, Massachusetts, United States 02118.
Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.
Boston University Medical Center General Clinical Research Unit has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Transthyretin (TTR) Amyloid Cardiomyopathy, Amyloid Cardiomyopathy, Transthyretin-Related, Pulmonary Arterial Hypertension.
Sponsors: Pfizer, Eidos Therapeutics, a BridgeBio company, United Therapeutics.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Massachusetts · View every site in Boston
Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Boston University Medical Center General Clinical Research Unit has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Boston University Medical Center General Clinical Research Unit has 3 clinical trials on record, with 1 currently active. Their work covers Transthyretin (TTR) Amyloid Cardiomyopathy, Amyloid Cardiomyopathy, Transthyretin-Related, Pulmonary Arterial Hypertension.
Boston University Medical Center General Clinical Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.